- What do we call an optimal intervention?
The optimal intervention combines clinical efficacy and outstanding safety while minimizing treatment cost for hospitals and insurers. In other words: the cost-effectiveness of a treatment choice is what ultimately matters.
Novel studies presented at CIRSE 2020 e-congress have further underlined the advantages of DCB use for PAD. Even more so, new study data is now available which demonstrates this specifically for AV Fistula patients. Advantages have been shown to not only exist in terms of clinical indicators & cost reduction but also in terms of reduced reinterventions & improvements in patient’s quality-adjusted-life-year.
Sing up with your representative for a Eurocor training on cost efficiency of DCBs in peripherals and discover scientifically grounded evidence that DCBs, across indications and across major healthcare systems, are projected to be the most cost-efficient treatment-option available.
